REZKALLA BUTROS: Open Payments
NPI 1023037082 · MT. STERLING, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,252 in 117 payments from 32 companies in 2025. Trend: 2023 $1,793 · 2024 $1,915 · 2025 $2,252
Food & beverage: $2,177Education: $76
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $306 |
| Novo Nordisk Inc | 11 | $275 |
| Otsuka America Pharmaceutical, Inc. | 12 | $243 |
| Lilly USA, LLC | 7 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| PFIZER INC. | 6 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $85 |
| CSL Behring | 3 | $78 |
| OPKO Pharmaceuticals, LLC | 4 | $76 |
Products named: Ozempic, JARDIANCE, JYNARQUE, REXULTI, CAPLYTA, ELIQUIS, LINZESS, Kerendia.
Industry payments across KY — which companies pay providers there.
